Literature DB >> 29420963

A Surprising Noncanonical Role for Calcineurin in Pressure-Induced Cardiac Hypertrophy.

Robin M Shaw1, Andriana P Nikolova2.   

Abstract

Entities:  

Keywords:  HFpEF; calcineurin; hypertrophy; splicing

Mesh：

Substances：

Year:  2018        PMID： 29420963      PMCID： PMC6478169          DOI： 10.1016/j.jacc.2017.12.008

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  9 in total

Review 1.  Cardiac metabolism in heart failure: implications beyond ATP production.

Authors:  Torsten Doenst; Tien Dung Nguyen; E Dale Abel
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

2.  Impaired cardiac hypertrophic response in Calcineurin Abeta -deficient mice.

Authors:  Orlando F Bueno; Benjamin J Wilkins; Kevin M Tymitz; Betty J Glascock; Thomas F Kimball; John N Lorenz; Jeffery D Molkentin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

3.  A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.

Authors:  J D Molkentin; J R Lu; C L Antos; B Markham; J Richardson; J Robbins; S R Grant; E N Olson
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

4.  Activation of Serine One-Carbon Metabolism by Calcineurin Aβ1 Reduces Myocardial Hypertrophy and Improves Ventricular Function.

Authors:  Laura Padrón-Barthe; María Villalba-Orero; Jesús M Gómez-Salinero; Rebeca Acín-Pérez; Sara Cogliati; Marina López-Olañeta; Paula Ortiz-Sánchez; Elena Bonzón-Kulichenko; Jesús Vázquez; Pablo García-Pavía; Nadia Rosenthal; José Antonio Enríquez; Enrique Lara-Pezzi
Journal:  J Am Coll Cardiol       Date:  2018-02-13       Impact factor: 24.094

5.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

6.  Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.

Authors:  Benjamin J Wilkins; Yan-Shan Dai; Orlando F Bueno; Stephanie A Parsons; Jian Xu; David M Plank; Fred Jones; Thomas R Kimball; Jeffery D Molkentin
Journal:  Circ Res       Date:  2003-12-01       Impact factor: 17.367

7.  Genetic inhibition of calcineurin induces diastolic dysfunction in mice with chronic pressure overload.

Authors:  Ricardo J Gelpi; Shumin Gao; Peiyong Zhai; Lin Yan; Chull Hong; Lauren M A Danridge; Hui Ge; Yasahiro Maejima; Martin Donato; Mitsuhiro Yokota; Jeffery D Molkentin; Dorothy E Vatner; Stephen F Vatner; Junichi Sadoshima
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

8.  GSH or palmitate preserves mitochondrial energetic/redox balance, preventing mechanical dysfunction in metabolically challenged myocytes/hearts from type 2 diabetic mice.

Authors:  Carlo G Tocchetti; Viviane Caceres; Brian A Stanley; Chaoqin Xie; Sa Shi; Walter H Watson; Brian O'Rourke; Regina C Spadari-Bratfisch; Sonia Cortassa; Fadi G Akar; Nazareno Paolocci; Miguel A Aon
Journal:  Diabetes       Date:  2012-07-17       Impact factor: 9.461

9.  A naturally occurring calcineurin variant inhibits FoxO activity and enhances skeletal muscle regeneration.

Authors:  Enrique Lara-Pezzi; Nadine Winn; Angelika Paul; Karl McCullagh; Esfir Slominsky; Maria Paola Santini; Foteini Mourkioti; Padmini Sarathchandra; Satsuki Fukushima; Ken Suzuki; Nadia Rosenthal
Journal:  J Cell Biol       Date:  2007-12-17       Impact factor: 10.539
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.